Milan, Italy

Daniela Zelaschi

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Ntc S.r.l.. Active years: 2018-2019.


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Daniela Zelaschi: Innovator in Allergy Treatment

Introduction

Daniela Zelaschi is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of allergy treatment through her innovative pharmaceutical compositions. With a total of 2 patents, her work focuses on providing effective solutions for allergy symptoms.

Latest Patents

Zelaschi's latest patents include a composition for the prevention and/or treatment of allergy symptoms. This invention relates to a pharmaceutical composition or a food supplement that aims to alleviate symptoms of allergic rhinitis and allergic conjunctivitis. The composition features at least one slow-release component containing quercetin and at least one fast-release component derived from extracts such as luteolin, rosmarinic acid, apigenin, catechin, ferulic acid, and caffeic acid. The invention emphasizes the use of this composition in preventing and treating allergy symptoms effectively.

Career Highlights

Daniela Zelaschi is associated with Ntc S.r.l., where she continues to develop her innovative ideas. Her work has garnered attention for its potential impact on improving the quality of life for individuals suffering from allergies.

Collaborations

Zelaschi collaborates with notable colleagues, including Cesare Busetti and Fabrizio Niccolai. Their combined expertise contributes to the advancement of research and development in the field of allergy treatment.

Conclusion

Daniela Zelaschi stands out as a dedicated inventor whose work in allergy treatment showcases her commitment to innovation. Her contributions are paving the way for new solutions in managing allergy symptoms.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…